Live Markets: Before the bell: Europe eyes best quarter since 2022
LIVE MARKETS-Before the bell: Europe eyes best quarter since 2022 Adds blog post
Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com
BEFORE THE BELL: EUROPE EYES BEST QUARTER SINCE 2022
Europe looks set to end a strong quarter on an upbeat note, with Euro STOXX 50 .STOXX50E and DAX .GDAXI futures up around 0.6-0.7%, as optimism around artificial intelligence continues to drive global equities.
The region-wide STOXX 600 .STOXX is up more than 9% this quarter, set for its strongest quarterly gain in three and a half years.
Chipmakers and AI-exposed industrials are likely to be the main leadership group at the open. Premarket indications point to gains of 2-3% for heavyweight technology names including ASML ASML.AS, STMicro STMPA.PA and Infineon IFXGn.DE, while Siemens Energy ENR1n.DE is up around 3% after reiterating strong demand trends and robust market momentum.
Shipping stocks are another area to watch after Maersk MAERSKb.CO upgraded full-year guidance on strong container demand. Maersk is called up 3-5%, with positive read-across for logistics peer DSV DSV.CO.
French biotech Abivax ABVX.PA is the standout mover, seen up 25-30% after positive ulcerative colitis data for obefazimod.
In UK retail, Sainsbury's SBRY.L reported slower underlying sales growth in its first quarter, though it left its full-year profit guidance unchanged.
(Danilo Masoni)
*****
EARLIER ON LIVE MARKETS:
INVESTORS GO SHOPPING FOR Q3 CLICK HERE
Recent news on Abivax SA
See all newsAbivax shares fall after rival drug data, trader says
France's Abivax H1 net loss widens on higher expenses driven by clinical programs
U.S. RESEARCH ROUNDUP-Caseys General Stores, Targa Resources, United Rentals
GS starts Abivax at 'buy,' sees multibillion sales potential for lead drug candidate
Europe's STOXX 600 ends week at all-time high on earnings support, soft US jobs data